Fei Chen Selected Research

Triple Negative Breast Neoplasms

1/2024	DDX58 deficiency leads to triple negative breast cancer chemotherapy resistance by inhibiting Type I IFN-mediated signalling apoptosis.
10/2022	Deletion of mdig enhances H3K36me3 and metastatic potential of the triple negative breast cancer cells.
1/2021	Clinical Progress of PD-1/L1 Inhibitors in Breast Cancer Immunotherapy.
1/2021	Novel Long Noncoding RNA 005620 Induces Epirubicin Resistance in Triple-Negative Breast Cancer by Regulating ITGB1 Expression.
11/2020	Bufalin attenuates triple-negative breast cancer cell stemness by inhibiting the expression of SOX2/OCT4.
7/2020	CRISPR-Cas9 gene editing causes alternative splicing of the targeting mRNA.
1/2020	RNA-seq analysis identified hormone-related genes associated with prognosis of triple negative breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fei Chen Research Topics

Disease

216	Neoplasms (Cancer) 04/2024 - 10/2002
42	Infections 04/2024 - 10/2005
42	Breast Neoplasms (Breast Cancer) 01/2024 - 06/2005
36	Inflammation (Inflammations) 05/2024 - 05/2002
33	Neoplasm Metastasis (Metastasis) 10/2023 - 04/2006
31	Carcinogenesis 02/2024 - 02/2002
30	COVID-19 03/2024 - 01/2020
30	Lung Neoplasms (Lung Cancer) 06/2023 - 07/2005
28	Hepatocellular Carcinoma (Hepatoma) 08/2023 - 10/2004
18	Fibrosis (Cirrhosis) 04/2024 - 07/2005
14	Carcinoma (Carcinomatosis) 05/2024 - 02/2008
14	Stroke (Strokes) 01/2024 - 09/2012
14	Necrosis 11/2021 - 08/2003
13	Pain (Aches) 10/2022 - 10/2008
13	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 08/2004
12	Ischemic Stroke 01/2024 - 09/2012
12	Colonic Neoplasms (Colon Cancer) 01/2022 - 11/2003
11	Hemorrhage 01/2024 - 10/2008
11	Coronary Artery Disease (Coronary Atherosclerosis) 01/2024 - 08/2014
11	Type 2 Diabetes Mellitus (MODY) 12/2023 - 06/2005
11	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2008
10	Pancreatic Neoplasms (Pancreatic Cancer) 05/2024 - 07/2017
10	Cardiovascular Diseases (Cardiovascular Disease) 06/2023 - 01/2013
10	Hypoxia (Hypoxemia) 01/2022 - 05/2005
9	Hypertension (High Blood Pressure) 01/2024 - 07/2007
9	Heart Failure 01/2023 - 07/2007
9	Stomach Neoplasms (Stomach Cancer) 01/2022 - 07/2017
8	Lung Diseases (Lung Disease) 01/2023 - 05/2002
8	Body Weight (Weight, Body) 06/2022 - 01/2016
7	Diabetes Mellitus 04/2024 - 01/2015
7	Pathologic Constriction (Stenosis) 03/2024 - 01/2015
7	Triple Negative Breast Neoplasms 01/2024 - 01/2020
7	Melanoma (Melanoma, Malignant) 12/2023 - 01/2017
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2023 - 05/2013
7	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 12/2010
7	Liver Neoplasms (Liver Cancer) 01/2021 - 02/2009
6	Wounds and Injuries (Trauma) 05/2024 - 10/2011
6	Osteoporosis 01/2024 - 06/2018
6	Obesity 12/2023 - 01/2012
6	Osteoarthritis 12/2023 - 12/2020
6	Chronic Obstructive Pulmonary Disease (COPD) 12/2023 - 01/2021
6	Liver Diseases (Liver Disease) 11/2023 - 01/2017
6	Thyroid Neoplasms (Thyroid Cancer) 01/2021 - 01/2008
6	Tuberculosis (Tuberculoses) 01/2019 - 02/2002
5	Adenocarcinoma 05/2024 - 07/2014
5	Pneumonia (Pneumonitis) 04/2024 - 07/2005
5	Ovarian Neoplasms (Ovarian Cancer) 04/2024 - 03/2005
5	Rupture 03/2024 - 01/2005
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2024 - 08/2018
5	Cognitive Dysfunction 01/2024 - 11/2021

Drug/Important Bio-Agent (IBA)

62	Proteins (Proteins, Gene)FDA Link 02/2024 - 06/2002
40	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2014
22	CytokinesIBA 01/2024 - 05/2002
21	RNA (Ribonucleic Acid)IBA 12/2023 - 12/2016
21	Long Noncoding RNAIBA 08/2023 - 09/2015
20	ArsenicIBA 02/2024 - 11/2005
19	NF-kappa B (NF-kB)IBA 01/2024 - 02/2002
17	Therapeutic UsesIBA 06/2023 - 05/2015
16	LigandsIBA 04/2024 - 11/2003
16	Messenger RNA (mRNA)IBA 09/2023 - 07/2005
15	MicroRNAs (MicroRNA)IBA 11/2023 - 06/2010
14	Glucose (Dextrose)FDA LinkGeneric 02/2023 - 05/2008
13	Transcription Factors (Transcription Factor)IBA 01/2024 - 05/2002
13	MineralsIBA 10/2022 - 07/2005
12	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 04/2005
12	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023 - 02/2002
12	VaccinesIBA 12/2023 - 03/2011
12	EnzymesIBA 01/2023 - 07/2002
11	Peptides (Polypeptides)IBA 05/2024 - 06/2014
10	LipidsIBA 03/2024 - 07/2002
9	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024 - 11/2019
9	Antiviral Agents (Antivirals)IBA 01/2024 - 01/2018
9	Interleukin-6 (Interleukin 6)IBA 01/2024 - 01/2013
9	CateninsIBA 12/2023 - 08/2012
8	ChromatinIBA 01/2024 - 08/2003
8	Phosphotransferases (Kinase)IBA 11/2021 - 08/2004
7	Dexamethasone (Maxidex)FDA LinkGeneric 11/2023 - 01/2010
7	ErbB Receptors (EGF Receptor)IBA 06/2023 - 12/2013
7	CholesterolIBA 01/2023 - 04/2017
7	CarcinogensIBA 04/2022 - 02/2002
6	Interleukin-10 (Interleukin 10)IBA 12/2023 - 01/2012
6	AntigensIBA 09/2023 - 12/2006
6	Triglycerides (Triacylglycerol)IBA 01/2023 - 11/2016
6	Cisplatin (Platino)FDA LinkGeneric 06/2022 - 03/2005
6	Histones (Histone)IBA 01/2021 - 02/2009
5	HydrogelsIBA 05/2024 - 12/2020

Therapy/Procedure

85	Therapeutics 02/2024 - 08/2004
22	Drug Therapy (Chemotherapy) 01/2024 - 12/2004
20	Immunotherapy 04/2024 - 07/2015
13	Radiotherapy 03/2024 - 03/2009
9	Transplantation 01/2024 - 05/2008
8	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2023 - 03/2015
7	Transcatheter Aortic Valve Replacement 11/2022 - 12/2020
7	Length of Stay 07/2021 - 01/2011
6	Thrombectomy 01/2024 - 02/2020
6	Percutaneous Coronary Intervention 11/2023 - 11/2020
6	Aftercare (After-Treatment) 10/2023 - 01/2015
6	Perforator Flap 09/2023 - 01/2019
6	Precision Medicine 01/2023 - 03/2015
6	Lasers (Laser) 02/2022 - 10/2007